Multiclass recognition of Alzheimer’s and Parkinson’s disease using various machine learning techniques: A study

2021 ◽  
Author(s):  
Chetan Balaji ◽  
D. S. Suresh
Keyword(s):  
Machine Learning ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Early Diagnosis ◽  
Neurodegenerative Disorder ◽  
Early Stage ◽  
Ensemble Methods ◽  
Machine Learning Techniques ◽  
Support Vector ◽  
Input Space

The aging population is primarily affected by Alzheimer’s disease (AD) that is an incurable neurodegenerative disorder. There is a need for an automated efficient technique to diagnose Alzheimer’s in its early stage. Various techniques are used to diagnose AD. EEG and neuroimaging methodologies are widely used to highlight changes in the electrical activity of the brain signals that are helpful for early diagnosis. Parkinson’s disease (PD) is a major neurological disease that results in an average of 50,000 new clinical diagnoses worldwide every year. The voice features are majorly used as the main means to diagnose PD. The major symptoms of PD are loss of intensity, the monotony of loudness and pitch, reduction in stress, unidentified silences, and dysphonia. Even though various innovative models are proposed by explorers about Alzheimer’s and Parkinson’s classification diseases, still there is a need for efficient learning methodologies and techniques. This paper provides a review on using machine learning (ML) together with several feature extraction techniques that is helpful in the early detection of AD with Parkinson’s. The novelty and objective of this study are that the CAD technique is used to improve the accuracy of early diagnosis of AD. The proposed technique depends on the nonlinear process for data dimension reduction, feature removal, and classification using kernel-based support vector machine (SVM) classifiers. The dimension of the input space is radically diminished with kernel methods. As the learning set is labeled, it creates sense to utilize this information to make a dependable method of dropping the input space dimension. The different techniques of ML are explained under the major approaches viz. SVM, artificial neural network (ANN), deep learning (DL), and ensemble methods. A comprehensive assessment is presented at SVM, ANN, and DL approaches for better detection of Alzheimer’s with PD highlighting future insights.

scholarly journals A Supervised Machine Learning Approach to Detect the On/Off State in Parkinson’s Disease Using Wearable Based Gait Signals

Diagnostics ◽  
2020 ◽  
Vol 10 (6) ◽  
pp. 421
Author(s):  
Satyabrata Aich ◽  
Jinyoung Youn ◽  
Sabyasachi Chakraborty ◽  
Pyari Mohan Pradhan ◽  
Jin-han Park ◽  
...  
Keyword(s):  
Machine Learning ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Random Forest ◽  
Wearable Devices ◽  
Supervised Machine Learning ◽  
Machine Learning Techniques ◽  
Support Vector ◽  
Healthcare Applications ◽  
Reported Data

Fluctuations in motor symptoms are mostly observed in Parkinson’s disease (PD) patients. This characteristic is inevitable, and can affect the quality of life of the patients. However, it is difficult to collect precise data on the fluctuation characteristics using self-reported data from PD patients. Therefore, it is necessary to develop a suitable technology that can detect the medication state, also termed the “On”/“Off” state, automatically using wearable devices; at the same time, this could be used in the home environment. Recently, wearable devices, in combination with powerful machine learning techniques, have shown the potential to be effectively used in critical healthcare applications. In this study, an algorithm is proposed that can detect the medication state automatically using wearable gait signals. A combination of features that include statistical features and spatiotemporal gait features are used as inputs to four different classifiers such as random forest, support vector machine, K nearest neighbour, and Naïve Bayes. In total, 20 PD subjects with definite motor fluctuations have been evaluated by comparing the performance of the proposed algorithm in association with the four aforementioned classifiers. It was found that random forest outperformed the other classifiers with an accuracy of 96.72%, a recall of 97.35%, and a precision of 96.92%.

scholarly journals An Optimized Brain-Based Algorithm for Classifying Parkinson’s Disease

2020 ◽  
Vol 10 (5) ◽  
pp. 1827 ◽  
Author(s):  
Rodrigo Olivares ◽  
Roberto Munoz ◽  
Ricardo Soto ◽  
Broderick Crawford ◽  
Diego Cárdenas ◽  
...  
Keyword(s):  
Machine Learning ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Extreme Learning Machine ◽  
Neurodegenerative Disorder ◽  
Fine Tuning ◽  
Machine Learning Techniques ◽  
Learning Approaches ◽  
Classification Problems ◽  
Learning Machine

During the last years, highly-recognized computational intelligence techniques have been proposed to treat classification problems. These automatic learning approaches lead to the most recent researches because they exhibit outstanding results. Nevertheless, to achieve this performance, artificial learning methods firstly require fine tuning of their parameters and then they need to work with the best-generated model. This process usually needs an expert user for supervising the algorithm’s performance. In this paper, we propose an optimized Extreme Learning Machine by using the Bat Algorithm, which boosts the training phase of the machine learning method to increase the accuracy, and decreasing or keeping the loss in the learning phase. To evaluate our proposal, we use the Parkinson’s Disease audio dataset taken from UCI Machine Learning Repository. Parkinson’s disease is a neurodegenerative disorder that affects over 10 million people. Although its diagnosis is through motor symptoms, it is possible to evidence the disorder through variations in the speech using machine learning techniques. Results suggest that using the bio-inspired optimization algorithm for adjusting the parameters of the Extreme Learning Machine is a real alternative for improving its performance. During the validation phase, the classification process for Parkinson’s Disease achieves a maximum accuracy of 96.74% and a minimum loss of 3.27%.

scholarly journals A Study On Deep Learning And Machine Learning Techniques On Detection Of Parkinson’s Disease

2021 ◽  
Vol 309 ◽  
pp. 01008
Author(s):  
P. Mounika ◽  
S. Govinda Rao
Keyword(s):  
Machine Learning ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Deep Learning ◽  
Early Stage ◽  
Signs And Symptoms ◽  
Machine Learning Techniques ◽  
Learning Approaches ◽  
Machine Learning Methods ◽  
Learning Techniques

Parkinson’s disease (PD) is a sophisticated anxiety malady that impairs movement. Symptoms emerge gradually, initiating with a slight tremor in only one hand occasionally. Tremors are prevalent, although the condition is sometimes associated with stiffness or slowed mobility. In the early degrees of PD, your face can also additionally display very little expression. Your fingers won’t swing while you walk. Your speech can also additionally grow to be gentle or slurred. PD signs and symptoms get worse as your circumstance progresses over time. The goal of this study is to test the efficiency of deep learning and machine learning approaches in order to identify the most accurate strategy for sensing Parkinson’s disease at an early stage. In order to measure the average performance most accurately, we compared deep learning and machine learning methods.

scholarly journals A Sensor-Based Perspective in Early-Stage Parkinson’s Disease: Current State and the Need for Machine Learning Processes

Sensors ◽  
2022 ◽  
Vol 22 (2) ◽  
pp. 409
Author(s):  
Marios G. Krokidis ◽  
Georgios N. Dimitrakopoulos ◽  
Aristidis G. Vrahatis ◽  
Christos Tzouvelekis ◽  
Dimitrios Drakoulis ◽  
...  
Keyword(s):  
Machine Learning ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Neurodegenerative Disorder ◽  
Early Stage ◽  
Diagnostic System ◽  
Medical Systems ◽  
Body Protein ◽  
Ensemble Techniques ◽  
Current State

Parkinson’s disease (PD) is a progressive neurodegenerative disorder associated with dysfunction of dopaminergic neurons in the brain, lack of dopamine and the formation of abnormal Lewy body protein particles. PD is an idiopathic disease of the nervous system, characterized by motor and nonmotor manifestations without a discrete onset of symptoms until a substantial loss of neurons has already occurred, enabling early diagnosis very challenging. Sensor-based platforms have gained much attention in clinical practice screening various biological signals simultaneously and allowing researchers to quickly receive a huge number of biomarkers for diagnostic and prognostic purposes. The integration of machine learning into medical systems provides the potential for optimization of data collection, disease prediction through classification of symptoms and can strongly support data-driven clinical decisions. This work attempts to examine some of the facts and current situation of sensor-based approaches in PD diagnosis and discusses ensemble techniques using sensor-based data for developing machine learning models for personalized risk prediction. Additionally, a biosensing platform combined with clinical data processing and appropriate software is proposed in order to implement a complete diagnostic system for PD monitoring.

scholarly journals Classification of Parkinson’s disease and essential tremor based on gait and balance characteristics from wearable motion sensors: A data-driven approach

2020 ◽  
Author(s):  
Sanghee Moon ◽  
Hyun-Je Song ◽  
Vibhash D. Sharma ◽  
Kelly E. Lyons ◽  
Rajesh Pahwa ◽  
...  
Keyword(s):  
Machine Learning ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Essential Tremor ◽  
Movement Disorders ◽  
Machine Learning Techniques ◽  
Support Vector ◽  
Learning Models ◽  
Learning Techniques ◽  
Machine Learning Models

AbstractParkinson’s disease (PD) and essential tremor (ET) are movement disorders that can have similar clinical characteristics including tremor and gait difficulty. These disorders can be misdiagnosed leading to delay in appropriate treatment. The aim of the study was to determine whether gait and balance variables obtained with wearable sensors can be utilized to differentiate between PD and ET using machine learning techniques. Additionally, we compared classification performances of several machine learning models. A balance and gait data set collected from 567 people with PD or ET was investigated. Performance of several machine learning techniques including neural networks (NN), support vector machine (SVM), k-nearest neighbor (kNN), decision tree (DT), random forest (RF), and gradient boosting (GB), were compared using F1-scores. Machine learning models classified PD and ET based on balance and gait characteristics better than chance or logistic regression. The highest F1-score was 0.61 of NN, followed by 0.59 of GB, 0.56 of RF, 0.55 of SVM, 0.53 of DT, and 0.49 of kNN. The results demonstrated the utility of machine learning models to classify different movement disorders. Further study will provide a more accurate clinical tool to help clinical decision-making.

Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson’s Disease

2020 ◽  
Vol 26 (37) ◽  
pp. 4738-4746
Author(s):  
Mohan K. Ghanta ◽  
P. Elango ◽  
Bhaskar L. V. K. S.
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Early Diagnosis ◽  
Neurodegenerative Disorder ◽  
Therapeutic Strategies ◽  
Neuroprotective Agents ◽  
Striatal Neurons ◽  
The Status ◽  
Advanced Stages ◽  
Dopaminergic Pathways

Parkinson’s disease is a progressive neurodegenerative disorder of dopaminergic striatal neurons in basal ganglia. Treatment of Parkinson’s disease (PD) through dopamine replacement strategies may provide improvement in early stages and this treatment response is related to dopaminergic neuronal mass which decreases in advanced stages. This treatment failure was revealed by many studies and levodopa treatment became ineffective or toxic in chronic stages of PD. Early diagnosis and neuroprotective agents may be a suitable approach for the treatment of PD. The essentials required for early diagnosis are biomarkers. Characterising the striatal neurons, understanding the status of dopaminergic pathways in different PD stages may reveal the effects of the drugs used in the treatment. This review updates on characterisation of striatal neurons, electrophysiology of dopaminergic pathways in PD, biomarkers of PD, approaches for success of neuroprotective agents in clinical trials. The literature was collected from the articles in database of PubMed, MedLine and other available literature resources.

scholarly journals Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Faith L. Anderson ◽  
Katharine M. von Herrmann ◽  
Angeline S. Andrew ◽  
Yuliya I. Kuras ◽  
Alison L. Young ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cell Death ◽  
Nlrp3 Inflammasome ◽  
Neurodegenerative Disorder ◽  
Early Stage ◽  
Inflammasome Activation ◽  
Membrane Pore ◽  
Related Proteins ◽  
Inflammasome Activity

AbstractParkinson’s disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms and loss of dopaminergic neurons of the substantia nigra. Inflammation and cell death are recognized aspects of PD suggesting that strategies to monitor and modify these processes may improve the management of the disease. Inflammasomes are pro-inflammatory intracellular pattern recognition complexes that couple these processes. The NLRP3 inflammasome responds to sterile triggers to initiate pro-inflammatory processes characterized by maturation of inflammatory cytokines, cytoplasmic membrane pore formation, vesicular shedding, and if unresolved, pyroptotic cell death. Histologic analysis of tissues from PD patients and individuals with nigral cell loss but no diagnosis of PD identified elevated expression of inflammasome-related proteins and activation-related “speck” formation in degenerating mesencephalic tissues compared with controls. Based on previous reports of circulating inflammasome proteins in patients suffering from heritable syndromes caused by hyper-activation of the NLRP3 inflammasome, we evaluated PD patient plasma for evidence of inflammasome activity. Multiple circulating inflammasome proteins were detected almost exclusively in extracellular vesicles indicative of ongoing inflammasome activation and pyroptosis. Analysis of plasma obtained from a multi-center cohort identified elevated plasma-borne NLRP3 associated with PD status. Our findings are consistent with others indicating inflammasome activity in neurodegenerative disorders. Findings suggest mesencephalic inflammasome protein expression as a histopathologic marker of early-stage nigral degeneration and suggest plasma-borne inflammasome-related proteins as a potentially useful class of biomarkers for patient stratification and the detection and monitoring of inflammation in PD.

Sign in / Sign up

Export Citation Format

Share Document